Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2026-01-05 @ 6:34 PM
Study NCT ID:
NCT01443169
Status:
COMPLETED
Last Update Posted:
2021-01-22
First Post:
2011-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization: